Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,822
Closed -$207K 113
2024
Q3
$207K Hold
1,822
0.09% 103
2024
Q2
$226K Hold
1,822
0.1% 98
2024
Q1
$240K Sell
1,822
-500
-22% -$61.6K 0.11% 88
2023
Q4
$253K Hold
2,322
0.13% 82
2023
Q3
$239K Sell
2,322
-300
-11% -$32.3K 0.14% 79
2023
Q2
$303K Hold
2,622
0.15% 74
2023
Q1
$279K Sell
2,622
-103
-4% -$11.1K 0.15% 78
2022
Q4
$302K Buy
+2,725
New +$279K 0.16% 80

Other funds holding MRK

Madden Securities's MRK Position: Q4 2024 in Review

Madden Securities sold out of Merck (MRK) in Q4 2024, closing a stake of 1,822 shares — an estimated $207K sold.

Madden Securities first reported a position in MRK in Q4 2022 and held it in 8 quarters. The position peaked at $303K in Q2 2023. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Madden Securities reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Madden Securities sold 1,822 Merck shares in Q4 2024, an estimated $207K.
  • Madden Securities first reported a position in Merck in Q4 2022 and held it in 8 quarters.
  • Madden Securities's Merck position peaked at $303K in Q2 2023.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Madden Securities's 13F filing for Q4 2024, filed 29 Jan 2025.